companies: 9,912     total market cap: €102.449 T
$USD🇺🇸₹INR🇮🇳£GBP🇬🇧$CAD🇨🇦$AUD🇦🇺$NZD🇳🇿$HKD🇭🇰$SGD🇸🇬
Intersect ENT
XENT
#5595
Rank
€0.86 B
Marketcap
🇺🇸 USA
Country
25,48 €
Share price
0.00%
Change (1 day)
12.46%
Change (1 year)
💊 Pharmaceuticals🧬 Biotech
Categories

EPS for Intersect ENT (XENT)

EPS in 2020: -2,00 €

According to Intersect ENT's latest financial reports the company's current EPS (TTM) is -2,00 €. In 2020 the company made an earnings per share (EPS) of -2,00 € a decrease over its 2019 EPS that were of -1,24 €.

EPS history for Intersect ENT from 2012 to 2020

Annual EPS

Year EPS Change
2020-2,00 €62.04%
2019-1,24 €80.26%
2018-0,69 €35.71%
2017-0,51 €-37.08%
2016-0,80 €-12.75%
2015-0,92 €-36.65%
2014-1,45 €37.61%
2013-1,06 €24.93%
2012-0,85 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ocular Therapeutix
OCUL
-1,05 €-47.75%🇺🇸 USA
Anika Therapeutics
ANIK
-1,38 €-31.08%🇺🇸 USA
Haemonetics
HAE
2,29 €-214.12%🇺🇸 USA
ICON plc
ICLR
5,66 €-382.43%🇮🇪 Ireland

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
 CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2024 CompaniesMarketcap.com